Versant Venture Capital VI, L.P.

10% OwnerLENZ Therapeutics, Inc. (LENZ) · full profile →Form 4 · filed Aug 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10.3M
Net Open-Market Flow
-$10.3M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 18, 2025Sell(S)15K$38.56$582K963K
Aug 18, 2025Sell(S)31K$38.56$1.2M1.4M
Aug 15, 2025Sell(S)70K$39.50$2.8M978K
Aug 15, 2025Sell(S)145K$39.50$5.7M1.4M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-110163) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about LENZ insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000950170-25-110163"
Ask your agent
Use Arkolith to summarize insider buying and selling at LENZ Therapeutics, Inc.
over the last 90 days and cite the filings.